SLC39A5 and metabolic dysfunction-associated steatotic liver disease: NAFLD activity score and steatosis-activity-fibrosis score (sum of NAFLD activity score and fibrosis score) were significantly reduced in female NASH Slc39a5-/- mice, but not in their male counterparts (Figure 6F and I and Figure 6—figure supplement 1F and I).